Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Glucagon like peptide-1-induced glucose metabolism in differentiated human muscle satellite cells is attenuated by hyperglycemia.

Green CJ, Henriksen TI, Pedersen BK, Solomon TP.

PLoS One. 2012;7(8):e44284. doi: 10.1371/journal.pone.0044284. Epub 2012 Aug 28.

2.

Aqueous fraction of Beta vulgaris ameliorates hyperglycemia in diabetic mice due to enhanced glucose stimulated insulin secretion, mediated by acetylcholine and GLP-1, and elevated glucose uptake via increased membrane bound GLUT4 transporters.

Ul Kabir A, Samad MB, Ahmed A, Jahan MR, Akhter F, Tasnim J, Hasan SM, Sayfe SS, Hannan JM.

PLoS One. 2015 Feb 3;10(2):e0116546. doi: 10.1371/journal.pone.0116546. eCollection 2015.

3.
4.

Regulation of glucose transporters and hexose uptake in 3T3-L1 adipocytes: glucagon-like peptide-1 and insulin interactions.

Wang Y, Kole HK, Montrose-Rafizadeh C, Perfetti R, Bernier M, Egan JM.

J Mol Endocrinol. 1997 Dec;19(3):241-8.

PMID:
9460645
5.

Characteristics of GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle.

Arnés L, González N, Tornero-Esteban P, Sancho V, Acitores A, Valverde I, Delgado E, Villanueva-Peñacarrillo ML.

Int J Mol Med. 2008 Jul;22(1):127-32.

PMID:
18575785
6.

Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes.

Luque MA, González N, Márquez L, Acitores A, Redondo A, Morales M, Valverde I, Villanueva-Peñacarrillo ML.

J Endocrinol. 2002 Jun;173(3):465-73.

7.

Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1.

Bulotta A, Hui H, Anastasi E, Bertolotto C, Boros LG, Di Mario U, Perfetti R.

J Mol Endocrinol. 2002 Dec;29(3):347-60.

PMID:
12459036
9.

Glucose exposure pattern determines glucagon-like peptide 1 receptor expression and signaling through endoplasmic reticulum stress in rat insulinoma cells.

Cheong YH, Kim MK, Son MH, Kaang BK.

Biochem Biophys Res Commun. 2011 Oct 14;414(1):220-5. doi: 10.1016/j.bbrc.2011.09.061. Epub 2011 Sep 17.

PMID:
21945929
10.

Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.

Bahrami J, Longuet C, Baggio LL, Li K, Drucker DJ.

Gastroenterology. 2010 Sep;139(3):857-68. doi: 10.1053/j.gastro.2010.05.006. Epub 2010 Jun 11.

PMID:
20546737
11.

Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.

Knauf C, Cani PD, Perrin C, Iglesias MA, Maury JF, Bernard E, Benhamed F, Grémeaux T, Drucker DJ, Kahn CR, Girard J, Tanti JF, Delzenne NM, Postic C, Burcelin R.

J Clin Invest. 2005 Dec;115(12):3554-63.

12.

Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.

Flamez D, Van Breusegem A, Scrocchi LA, Quartier E, Pipeleers D, Drucker DJ, Schuit F.

Diabetes. 1998 Apr;47(4):646-52.

PMID:
9568699
13.

Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.

Johnson KM, Edgerton DS, Rodewald T, Scott M, Farmer B, Neal D, Cherrington AD.

Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E380-4. Epub 2007 Dec 4.

14.

Subthreshold α₂-adrenergic activation counteracts glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion.

Pan M, Yang G, Cui X, Yang SN.

Exp Diabetes Res. 2011;2011:604989. doi: 10.1155/2011/604989. Epub 2010 Dec 27. Erratum in: Exp Diabetes Res. 2011;2011:319202.

15.

Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states.

Moreno P, Nuche-Berenguer B, Gutiérrez-Rojas I, Acitores A, Sancho V, Valverde I, González N, Villanueva-Peñacarrillo ML.

J Mol Endocrinol. 2012 Jan 25;48(1):37-47. doi: 10.1530/JME-11-0127. Print 2012 Feb.

PMID:
22065862
16.

The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.

Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T.

Breast Cancer Res Treat. 2012 Apr;132(2):449-61. doi: 10.1007/s10549-011-1585-0. Epub 2011 Jun 3.

PMID:
21638053
17.

Differential effects of glucagon-like peptide-1 on microvascular recruitment and glucose metabolism in short- and long-term insulin resistance.

Sjøberg KA, Rattigan S, Jeppesen JF, Lundsgaard AM, Holst JJ, Kiens B.

J Physiol. 2015 May 1;593(9):2185-98. doi: 10.1113/JP270129. Epub 2015 Mar 19.

18.

Brain GLP-1 signaling regulates femoral artery blood flow and insulin sensitivity through hypothalamic PKC-δ.

Cabou C, Vachoux C, Campistron G, Drucker DJ, Burcelin R.

Diabetes. 2011 Sep;60(9):2245-56. doi: 10.2337/db11-0464. Epub 2011 Aug 1.

19.

Characteristic of GLP-1 effects on glucose metabolism in human skeletal muscle from obese patients.

Villanueva-Peñacarrillo ML, Martín-Duce A, Ramos-Álvarez I, Gutiérrez-Rojas I, Moreno P, Nuche-Berenguer B, Acitores A, Sancho V, Valverde I, González N.

Regul Pept. 2011 Jun 7;168(1-3):39-44. doi: 10.1016/j.regpep.2011.03.002. Epub 2011 Mar 16.

PMID:
21419173
20.

In vivo suppression of visfatin by oral glucose uptake: evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1).

Bala M, Martin J, Kopp A, Hanses F, Buechler C, Schäffler A.

J Clin Endocrinol Metab. 2011 Aug;96(8):2493-501. doi: 10.1210/jc.2011-0342. Epub 2011 Jun 15.

PMID:
21677044

Supplemental Content

Support Center